Skip to main content
Log in

Prevalence of CYP2D6-metabolised drug use varies

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Mulder H, Heerdink ER, van Iersel EE, Wilmink FW, Egberts ACG.Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional study. Annals of Pharmacotherapy 41: 408-413, No. 3, Mar 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prevalence of CYP2D6-metabolised drug use varies. Pharmacoecon. Outcomes News 527, 7 (2007). https://doi.org/10.1007/BF03309415

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03309415

Keywords

Navigation